Erratum

Erratum:“Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer” by Roth et al. [JNCI J Natl Cancer Inst 2012; 104: 1635–1646]

Older versions of Figures 3 and 4 were inadvertently submitted with the final manuscript. The corrected versions are as follows:

Figure 3.

Kaplan–Meier curves incorporating patient tumor microsatellite instability (MSI) status in selected TNM subgroups. A) Relapse-free survival (RFS) and B) overall survival (OS), respectively, in stage II patients with T3N0 and T4N0 tumors with 95% confidence bands shown as dotted and dashed lines (censoring marks have been suppressed for clarity) and with T3N0 and T4N0 subdivided by MSI status as indicated. LOE = loss of expression; MSI-H = microsatellite instability high; MS-L/S = microsatellite instability low and microsatellite stable.

Figure 4.

Kaplan–Meier curves incorporating patient tumor microsatellite instability (MSI) status and SMAD4 expression status in selected TNM subgroups. A) Relapse-free survival (RFS) and B) overall survival (OS), respectively in patients with T3N1 tumors with 95% confidence bands as shown as dashed lines (censoring marks suppressed) and with T3N1 tumors subdivided by MSI and SMAD4 status as indicated (no curve is shown for the group of six patients that were microsatellite instability high [MSI-H] with loss of SMAD4 expression). Curves for T3N0 and T3N2 are shown for reference (black as indicated, censoring marks suppressed). LOE = loss of expression; MS-L/S = microsatellite instability low and microsatellite stable.

The authors regret this error.